180-Day Exclusivity and Authorized Generics: Legal Considerations in U.S. Drug Markets
The 180-day exclusivity rule was meant to reward generic drug companies that challenge patents. But brand-name companies can launch their own versions - authorized generics - during that time, undercutting the reward and slowing real competition.